LINCOLN
Invest with MTF
Invest Now
Invest in Lincoln Pharmaceuticals with 3.14X leverage
Performance
- Low
- ₹453
- High
- ₹461
- 52 Week Low
- ₹440
- 52 Week High
- ₹809
- Open Price₹460
- Previous Close₹461
- Volume8,356
- 50 DMA₹479.74
- 100 DMA₹499.95
- 200 DMA₹531.89
Investment Returns
- Over 1 Month -5.41%
- Over 3 Month -11.97%
- Over 6 Month -23.51%
- Over 1 Year -38.62%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.5
- PEG Ratio
- -0.7
- Market Cap Cr
- 921
- P/B Ratio
- 1.3
- Average True Range
- 14.95
- EPS
- 39.94
- Dividend Yield
- 0.4
- MACD Signal
- -6.96
- RSI
- 44.62
- MFI
- 35.36
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹459.80
-1.3
(-0.28%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹465.91
- 50 Day
- ₹479.74
- 100 Day
- ₹499.95
- 200 Day
- ₹531.89
Resistance and Support
457.75
- R3 470.25
- R2 465.40
- R1 462.60
- S1 454.95
- S2 450.10
- S3 447.30
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹459 As on 08 February, 2026 | 15:06
The Market Cap of Lincoln Pharmaceuticals is ₹921 Cr As on 08 February, 2026 | 15:06
The P/E ratio of Lincoln Pharmaceuticals is 11.5 As on 08 February, 2026 | 15:06
The PB ratio of Lincoln Pharmaceuticals is 1.3 As on 08 February, 2026 | 15:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.